Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Mocertatug Rezetecan in Platinum-Resistant Ovarian Carcinoma: NCT07286266 Clinical Landscape Report 2026
15 October 2026
NCT07286266 clinical landscape for Platinum-Resistant Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Carboplatin in Ovarian Cancer: NCT07278336 Clinical Landscape Report 2026
15 October 2026
NCT07278336 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nicotinamide mononucleotide in Alzheimer Disease: NCT07278492 Clinical Landscape Report 2026
15 October 2026
NCT07278492 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Locally Advanced Cervical Carcinoma: NCT07286253 Clinical Landscape Report 2026
15 October 2026
NCT07286253 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
RO-7268489 in Multiple Sclerosis, Chronic Progressive: NCT07282574 Clinical Landscape Report 2026
15 October 2026
NCT07282574 clinical landscape for Multiple Sclerosis, Chronic Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Iparomlimab/Tuvonralimab in Recurrent ovarian cancer: NCT07286240 Clinical Landscape Report 2026
15 October 2026
NCT07286240 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Ovarian Cancer: NCT07285941 Clinical Landscape Report 2026
15 October 2026
NCT07285941 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zasocitinib in Arthritis, Psoriatic: NCT07286058 Clinical Landscape Report 2026
15 October 2026
NCT07286058 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
EXV-801 in Alzheimer Disease: NCT07284472 Clinical Landscape Report 2026
15 October 2026
NCT07284472 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bimekizumab in Arthritis, Psoriatic: NCT07290036 Clinical Landscape Report 2026
15 October 2026
NCT07290036 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Revumenib in Acute Lymphoblastic Leukemia: NCT07283640 Clinical Landscape Report 2026
15 October 2026
NCT07283640 clinical landscape for Acute Lymphoblastic Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Capecitabine in Uterine Cervix Adenocarcinoma: CTRI/2025/12/099353 Clinical Landscape Report 2026
15 October 2026
CTRI/2025/12/099353 clinical landscape for Uterine Cervix Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…